Circadian aspects of growth hormoneinsulin-like growth factor axis function in patients with lung cancer

Clinical Lung Cancer

Volumn 13, Issue 1, 2012, Pages 68-74

  Mazzoccoli, Gianluigi ^a   Sothern, Robert B ^b   Pazienza, Valerio ^a   Piepoli, Ada ^a   Muscarella, Lucia Anna ^a   Giuliani, Francesco ^a   Tarquini, Roberto ^c  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Circadian rhythmicity; GH; IGF1; IL 2; Lung cancer; Melatonin

Indexed keywords

GROWTH HORMONE; INTERLEUKIN 2; MELATONIN; SOMATOMEDIN;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HORMONE RELEASE; HUMAN; LUNG NON SMALL CELL CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-2; LUNG NEOPLASMS; MALE; MELATONIN; MIDDLE AGED; PROGNOSIS;

EID: 84855692714     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2011.03.034     Document Type: Article

References (58)

1. J. Ayuk, M.C. Sheppard Growth hormone and its disorders Postgrad Med J 82 2006 24 30 (Pubitemid 43111799)
2. W.F. Blum, K. Albertsson-Wikland, S. Rosberg Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion J Clin Endocrinol Metab 76 1993 1610 1616 (Pubitemid 23164387)
3. M.F. Rudd, E.L. Webb, A. Matakidou GELCAPS Consortium Variants in the GH-IGF axis confer susceptibility to lung cancer Genome Res 16 2006 693 701 (Pubitemid 43830689)
4. J.K. Perry, B.S. Emerald, H.C. Mertani The oncogenic potential of growth hormone Growth Hormone IGF Res 16 2006 277 289 (Pubitemid 44793716)
5. R.E. Humbel Insulin-like growth factors I and II Eur J Biochem 190 1990 445 462
6. H. Werner, D. LeRoith The role of the insulin-like growth factor system in human cancer Adv Cancer Res 68 1996 183 223
7. J.A. Foekens, H. Portengen, W.L. van Putten Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer Cancer Res 15 1989 7002 7009 (Pubitemid 20016583)
8. D.L. Kleinberg, T.L. Wood, P.A. Furth Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions Endocrine Rev 30 2009 51 74
9. X. Wu, H. Yu, C.I. Amos Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk J Natl Cancer Inst 92 2000 737 743 (Pubitemid 30365534)
10. C. Gennigens, C. Menetrier-Caux, J.P. Droz Insulin-like growth factor (IGF) family and prostate cancer Crit Rev Oncol Hematol 58 2006 124 145
11. A.W. Roddam, N.E. Allen, P. Appleby Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies Ann Intern Med 149 2008 461 471
12. S. Rinaldi, R. Cleveland, T. Norat Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies Int J Cancer 126 2010 1702 1715
13. M.A. Rowlands, D. Gunnell, R. Harris Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis Int J Cancer 124 2009 2416 2429
14. E.A. Donovan, S. Kummar Role of insulin-like growth factor-1R system in colorectal carcinogenesis Crit Rev Oncol Hematol 66 2008 91 98 (Pubitemid 351446110)
15. K. Woodson, J.A. Tangrea, M. Pollak Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men Cancer Res 63 2003 3991 3994 (Pubitemid 36917917)
16. H. Lahm, L. Suardet, P.L. Laurent Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I,II and transforming growth factor alpha Br J Cancer 65 1992 341 346
17. W. Nelson, Y.L. Tong, F. Halberg Methods for cosinorrhytmometry Chronobiologia 6 1979 305 323
18. A. Mojón, J.R. Fernández, R. Hermida Chronolab: an interactive software package for chronobiologic time series analysis written for the Macintosh computer Chronobiol Intl 9 1992 403 412
19. P.J. Jenkins, A. Mukherjee, S.M. Shalet Does growth hormone cause cancer? Clin Endocrinol 64 2006 115 121
20. G. Mazzoccoli, M. Correra, G. Bianco Age-related changes of neuro-endocrine-immune interactions in healthy humans J Biol Regul Homeost Agents 11 1997 143 147 (Pubitemid 28161873)
21. G. Mazzoccoli, A. Giuliani, G. Bianco Decreased serum levels of insulin-like growth factor (IGF)-I in patients with lung cancer: temporal relationship with growth hormone (GH) levels Anticancer Res 19 1999 1397 1399 (Pubitemid 29257465)
22. L. Crown, K. Cottle, S.L. Lightman What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated? Clin Endocrinol 56 2002 723 733 (Pubitemid 34785903)
23. I. Okamoto, M. Munakata, M. Miyazaki Disturbance of the growth hormoneinsulin-like growth factor-1 axis associated with poor performance status in patients with solid tumors Jpn J Clin Oncol 40 2010 222 226
24. J. Oscarsson, G. Johansson, J.-O. Johansson Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficients adults Clin Endocrinol 46 1997 63 68 (Pubitemid 27072847)
25. K.C. Copeland, L.E. Underwood, J.J. Van Wyk Induction of immunoreactive somatomedin C in human serum by growth hormone: dose-response relationships and effect on chromatographic profiles J Clin Endocrinol Metab 50 1980 690 697 (Pubitemid 10009133)
26. J.O.L. Jorgensen, A. Flyvbyerg, T. Lauritzen Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients J Clin Endocrinol Metab 67 1988 36 40
27. J.O.L. Jorgensen, N. Moller, T. Lauritzen Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites J Clin Endocrinol Metab 70 1990 207 214
28. T. Laursen, J.O.L. Jorgensen, G. Jakobsen Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients J Clin Endocrinol Metab 80 1995 2410 2418
29. Y.J.H. Janssen, F. Helmerhorst, M. Frolich A switch from oral (2 mg/day) to transdermal (50 mg/day) 17b-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency J Clin Endocrinol Metab 85 2000 464 467 (Pubitemid 32268852)
30. F. Mercer, L. Kozhaya, D. Unutmaz Expression and function of TNF and IL-1 receptors on human regulatory T cells PLoS One 5 2010 e8639
31. N. Sanarico, A. Ciaramella, A. Sacchi Human monocyte-derived dendritic cells differentiated in the presence of IL-2 produce proinflammatory cytokines and prime Th1 immune response J Leukoc Biol 80 2006 555 562 (Pubitemid 44835789)
32. Y. Saijo, M. Tanaka, M. Miki Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction J Immunol 169 2002 469 475 (Pubitemid 34686169)
33. Z. Savtsova, O. Yudina, N. Fedosova The influence of antitumor vaccines of iepor series On TNF, Il-1 and Il-2 production in Lewis lung carcinoma bearing mice Exp Oncol 24 2002 295 300 (Pubitemid 36142591)
34. S.J. Won, W.T. Huang, Y.S. Lai Staphylococcal enterotoxin A acts through nitric oxide synthase mechanisms in human peripheral blood mononuclear cells to stimulate synthesis of pyrogenic cytokines Infect Immun 68 2000 2003 2008
35. A. Kasprzak, M. Zabel, W. Biczysko Expression of cytokines (TNF-alpha, IL-1alpha, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patients J Histochem Cytochem 52 2004 29 38 (Pubitemid 38032131)
36. D. Zwoliska, A. Medyska, K. Szprynger Serum concentration of IL-2, IL-6, TNF-alpha and their soluble receptors in children on maintenance hemodialysis Nephron 86 2000 441 446 (Pubitemid 32010729)
37. Y. Furukawa, K. Kobuke, A. Matsumori Role of cytokines in autoimmune myocarditis and cardiomyopathy Autoimmunity 34 2001 165 168 (Pubitemid 34149806)
38. J. Bentham, J. Rodriguez-Arnao, R.J.M. Ross Acquired growth hormone resistance in patients with hypercatabolism Horm Res 40 1993 87 91 (Pubitemid 23349948)
39. M. Pollak Insulin and insulin-like growth factor signalling in neoplasia Nature Rev Cancer 8 2008 915 928
40. K.J. Cullen, A. Allison, I. Martire Insulin-like growth factor expression in breast cancer epithelium and stroma Breast Cancer Res Treat 22 1992 21 29
41. K.A. Quinn, A.M. Treston, E.J. Unsworth Insulin-like growth factor expression in human cancer cell lines J Biol Chem 10 1996 11477 11483 (Pubitemid 26155990)
42. A. Friedl, V.C. Jordan, M. Pollak Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adiuvant tamoxifen therapy Eur J Cancer 29 1993 1368 1372 (Pubitemid 23195373)
43. R.R. Kazer Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis Int J Cancer 62 1995 403 406
44. Y. Oh, H.L. Muller, H. Pham Non-receptor mediated, post-transcriptional regulation of insulin-like growth factor binding protein (IGFBP)-3 in Hs578T human breast cancer cells Endocrinology 131 1992 3123 3125
45. M.J. Waters, B.L. Conway-Campbell The oncogenic potential of autocrine human growth hormone in breast cancer Proc Natl Acad Sci U S A 101 2004 14992 14993 (Pubitemid 39391704)
46. X. Wu, H. Yu, C.I. Amos Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk J Natl Cancer Inst 92 2000 737 743 (Pubitemid 30365534)
47. D.J. DeGraff, A.A. Aguiar, R.A. Sikes Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions Am J Transl Res 1 2009 115 130
48. P.D. Ryan, P.E. Goss The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer Oncologist 13 2008 16 24 (Pubitemid 351206693)
49. D. Sachdev, X. Zhang, I. Matise The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival Oncogene 1 2009 1 12
50. Unsala E, Koksala D, Yurdakula AS, et al. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer. Respir Med. 205; 99:559-65.
51. C. Braconi, R. Bracci, I. Bearzi Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients Ann Oncol 19 2008 1293 1298 (Pubitemid 351911960)
52. S.M. Luo, W.M. Tan, W.X. Deng Expression of albumin, IGF-1, IGFBP-3 in tumor tissues and adjacent non-tumor tissues of hepatocellular carcinoma patients with cirrhosis World J Gastroenterol 11 2005 4272 4276
53. Y. Gong, E. Yao, R. Shen High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507) PLoS One 4 2009 e7273
54. M. Anzo, L.J. Cobb, D.L. Hwang Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression Cancer Res 68 2008 3342 3349
55. C.J. Auernhammer, C.J. Strasburger Effects of growth hormone and insulin-like growth factor on the immune system Eur J Endocrinol 133 1995 635 645 (Pubitemid 26022220)
56. R. Clark The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function Endocrine Rev 18 1997 157 179 (Pubitemid 27171518)
57. J. Trojan, A. Ly, M.X. Wei Antisense anti IGF-I cellular therapy of malignant tumours: immune response in cancer patients Biomed Pharmacother 64 2010 576 578
58. L.H. Mayeenuddin, Y. Yu, Z. Kang Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-xL Oncogene 29 2010 6367-7